Article
Pharmacogenomics and Personalized Medicine
2012-01-01
Abstract excerpt
Great advances in genomic research on the susceptibility to multifactorial genetic diseases and drug sensitivities have broadened the use of genetic information in clinical practice. In the United States, pharmacogenomic information is included in drug package inserts (labels). The United States Food and Drug Administration releases a list of drugs and valid genomic biomarkers for public use. Also in Japan in June...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b5f2ebdf-a410-508b-be51-d140729616b3
- DOI
- 10.1272/manms.8.9